Jazz Pharmaceuticals Appoints Dr. Robert Iannone as Executive Vice President, Research and Development

DUBLIN, June 3, 2019 -- (Healthcare Sales & Marketing Network) -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced the appointment of Robert Iannone, M.D., M.S.C.E., as executive vice president, research and development, effective May 29, 2019. Dr.... Biopharmaceuticals, Oncology, Personnel Jazz Pharmaceuticals, Vyxeos, acute myeloid leukemia, myelodysplasia
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news